Lasting health starts with behavior change — and is accelerated by the right clinical tools. Today, we announced our acquisition of Tailor Made, a licensed 503A pharmacy. This marks Noom’s first major acquisition and our largest investment to date in healthy aging. By bringing pharmacy capabilities in-house, we can more deeply integrate prescription-grade interventions into our behavior-change platform, while expanding our formulary beyond weight health. Be sure to read our CEO’s statement below and check out the podcast interview for more on the strategy behind Noom’s expansion beyond weight into healthy aging. You can also check out the press release here: https://lnkd.in/eXPcb7xu #Noom #HealthcareInnovation #preventivehealth
Noom acquired Tailor Made pharmacy today (❗) because while weight may be the entry point to preventive care, it’s not the end point. Beyond weight, eight other conditions define how well you age: energy, muscle health, stress and mood, gut health, hormonal balance, skin health, inflammation, and sleep. What's remarkable about all eight conditions is that pharmacologic intervention alone is not the answer – and neither, for many, is behavior change. The breakthrough is in the combination — when the right medication becomes an accelerant for the lifestyle change that makes it last. Tailor Made is a 503A pharmacy licensed in 46 states and Noom’s first ever major acquisition. Today we move 𝗯𝗲𝘆𝗼𝗻𝗱 𝘄𝗲𝗶𝗴𝗵𝘁 𝗵𝗲𝗮𝗹𝘁𝗵 into the non-acute, high-salience conditions that define healthy aging for hundreds of millions of people. Dr. Warner Slack of Harvard Medical School called the patient "the largest and least utilized resource in healthcare." Noom was built to fix that. By making healthy choices easier, we build durable health by 𝗺𝗮𝗸𝗶𝗻𝗴 𝗰𝗵𝗮𝗻𝗴𝗲 𝗹𝗮𝘀𝘁. Now with Tailor Made’s pharmacy integrated alongside at-home diagnostics and wearable data, Noom can deliver on the promise of Med 3.0: the most data, the best lifestyle support, the most lasting outcomes. 𝗪𝗵𝘆 𝗻𝗼𝘄? Just last month, the HHS Secretary confirmed what many have long expected: the grey-market in research-grade peptides is, thankfully, at its end. The responsible phase is beginning. The acquisition today readies us for this future. Sermorelin, NAD+, and the neuropeptide oxytocin are early examples of a new frontier in preventive medicine. With government action to expand this list to include other peptides, like BPC-157 and CJC-1295 / Ipamorelin, regulated pharmacies like Tailor Made become critical infrastructure to meet accelerating patient demand. What enables today’s acquisition is Noom’s growth. 𝗡𝗼𝗼𝗺 𝗠𝗲𝗱 𝗿𝗲𝘃𝗲𝗻𝘂𝗲 𝗶𝘀 𝘂𝗽 𝟵𝟬% 𝘆𝗲𝗮𝗿 𝗼𝘃𝗲𝗿 𝘆𝗲𝗮𝗿. We believe continued expansion into healthy aging is critical to sustaining that trajectory — and to fulfilling our mission: to empower everyone, everywhere to live better longer—every day. I am thrilled to collaborate with Tailor Made's talented CEO Ross Jordan, JD, MBA, and I am grateful to the talented Noom and Tailor Made teams for all they have built and now will build. And ... 𝘄𝗲𝗹𝗰𝗼𝗺𝗲 👋 to the 200 new employees who joined the Noom family today! Together we will create the future of preventive care. For much more on the acquisition and on Noom, listen to my interview today with Jonathan Stern on the must-listen 𝗛𝗶𝗺𝘀 𝗛𝗼𝘂𝘀𝗲 podcast: https://lnkd.in/eaCMiP_r #preventivehealth #healthyaging #Noom